Skip to main content

OrbiMed Capital GP VIII LLC

In the past year, 3 open-market purchase filings worth $26.0M and 2 sale filings worth $9.13M.

Current role at each company

Show 5 more companies

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
$26.0M
3 filings
Sold
$9.13M
2 filings
Net
+$16.9M
Bought minus sold
Companies
4
With open-market trades

Trades

Every Form 4 that lists OrbiMed Capital GP VIII LLC as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

BLSM BlossomHill Therapeutics, Inc.

Director1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 12, 2026 (view filing)4:43 PM ETAug 102 daysOrbiMed Advisors LLC and 1 otherDirectorPPurchase+625.0K$16.00+$10.0M+29.9%2.71M after

SCTX Scribe Therapeutics, Inc.

Director1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 29, 2026 (view filing)6:47 PM ETJul 272 daysOrbiMed Advisors LLC and 1 otherDirectorPPurchase+1.00M$15.00+$15.0M+286.7%1.35M after

SION Sionna Therapeutics, Inc.

Director11 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 9, 2026 (view filing)4:44 PM ETJul 72 daysOrbiMed Advisors LLC and 1 otherDirectorSSale−85.9K$44.86−$3.85M−3.4%2.47M after10b5-1
Jul 2, 2026 (view filing)4:42 PM ETJun 302 daysOrbiMed Advisors LLC and 1 otherDirectorSSale−115.8K$45.50−$5.27M−4.3%2.56M after10b5-1
May 29, 2026 (view filing)8:57 PM ETMay 272 daysOrbiMed Advisors LLC and 1 otherDirectorSSale−101$44.49−$4.49K0.0%2.67M after10b5-1Duplicate filing
May 11, 2026 (view filing)6:58 PM ETMay 7-114 daysOrbiMed Advisors LLC and 1 otherDirectorSSale−293.0K$45.62−$13.4M−9.9%2.67M after3 lots10b5-1Duplicate filing
Apr 21, 2026 (view filing)8:40 PM ETApr 17-184 daysOrbiMed Advisors LLC and 1 otherDirectorSSale−55.3K$44.67−$2.47M−1.8%2.96M after2 lots10b5-1Duplicate filing
Apr 16, 2026 (view filing)7:03 PM ETApr 14-162 daysOrbiMed Advisors LLC and 1 otherDirectorSSale−510.6K$44.94−$22.9M−14.5%3.02M after3 lots10b5-1Duplicate filing
Feb 4, 2026 (view filing)7:39 PM ETFeb 2-32 daysOrbiMed Advisors LLC and 1 otherDirectorSSale−31.0K$44.58−$1.38M−0.9%3.53M after2 lots10b5-1Duplicate filing
Dec 29, 2025 (view filing)8:44 PM ETDec 245 daysOrbiMed Advisors LLC and 1 otherDirectorSSale−33.4K$44.55−$1.49M−0.9%3.56M after10b5-1Duplicate filing
Dec 19, 2025 (view filing)7:29 PM ETDec 17-192 daysOrbiMed Advisors LLC and 1 otherDirectorSSale−1.88K$44.49−$83.4K−0.1%3.60M after3 lots10b5-1Duplicate filing
Nov 26, 2025 (view filing)6:45 PM ETNov 24-262 daysOrbiMed Advisors LLC and 1 otherDirectorSSale−108.1K$44.55−$4.81M−2.9%3.60M after3 lots10b5-1Duplicate filing

See all 11 trades at SION

TRAW Traws Pharma, Inc.

10% Owner3 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Apr 28, 2026 (view filing)9:41 PM ETApr 1612 daysLateOrbiMed Advisors LLC and 1 other10% OwnerPPurchase+597.7K$1.67+$998.2K+98.7%1.20M after
Apr 28, 2026 (view filing)9:41 PM ETApr 1612 daysLateOrbiMed Advisors LLC and 1 other10% OwnerPPurchase+2.99M–––1.79M afterDerivative3 lots
Jan 27, 2025 (view filing)7:03 PM ETDec 29, 202429 daysLateOrbiMed Advisors LLC and 1 other10% OwnerPPurchase+192.7K–––96.3K afterDerivative2 lotsDuplicate filing

IRON Disc Medicine, Inc.

Director8 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Mar 26, 2025 (view filing)7:00 PM ETMar 242 daysOrbiMed Advisors LLC and 3 othersDirectorSSale−5.74K$54.11−$310.5K−3.0%186.5K after3 lotsDuplicate filing
Mar 21, 2025 (view filing)8:00 PM ETMar 19-212 daysOrbiMed Advisors LLC and 3 othersDirectorSSale−52.4K$54.02−$2.83M−21.9%187.3K after9 lotsDuplicate filing
Mar 12, 2025 (view filing)9:34 PM ETMar 10-122 daysOrbiMed Advisors LLC and 3 othersDirectorSSale−312.4K$54.31−$17.0M−61.7%194.2K after15 lotsDuplicate filing
Jun 20, 2024 (view filing)5:19 PM ETJun 173 daysOrbiMed Advisors LLC and 3 othersDirectorPPurchase+83.3K$36.00+$3.00M+54.8%235.4K after3 lotsDuplicate filing
Dec 20, 2023 (view filing)6:28 PM ETDec 182 daysOrbiMed Advisors LLC and 3 othersDirectorSSale−1.72K$59.24−$102.1K−100.0%0 afterDuplicate filing
Dec 15, 2023 (view filing)6:04 PM ETDec 141 dayOrbiMed Advisors LLC and 3 othersDirectorSSale−433.2K$56.75−$24.6M−65.9%224.4K after3 lotsDuplicate filing
Dec 14, 2023 (view filing)5:44 PM ETDec 12-142 daysOrbiMed Advisors LLC and 3 othersDirectorSSale−134.2K$58.88−$7.90M−15.6%727.8K after8 lotsDuplicate filing
Feb 17, 2023 (view filing)4:43 PM ETFeb 152 daysOrbiMed Advisors LLC and 3 othersDirector, 10% OwnerPPurchase+108.7K$23.00+$2.50M+57.1%299.2K after3 lotsDuplicate filing

UPB Upstream Bio, Inc.

Director, 10% Owner1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Oct 17, 2024 (view filing)4:17 PM ETOct 152 daysOrbiMed Advisors LLC and 3 othersDirector, 10% OwnerPPurchase+825.0K$17.00+$14.0M+22.1%4.55M after2 lotsDuplicate filing

AVBP ArriVent BioPharma, Inc.

Director, 10% Owner1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jan 31, 2024 (view filing)4:12 PM ETJan 301 dayOrbiMed Advisors LLC and 3 othersDirector, 10% OwnerPPurchase+444.4K$18.00+$8.00M+41.6%1.51M after2 lotsDuplicate filing

KNTE Kinnate Biopharma Inc.

Director, 10% Owner2 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 8, 2023 (view filing)5:22 PM ETMay 4-54 daysOrbiMed Advisors LLC and 6 othersDirector, 10% OwnerPPurchase+1.46M$2.80+$4.09MNew position1.37M after5 lotsDuplicate filing
May 2, 2023 (view filing)9:34 PM ETApr 28-May 24 daysOrbiMed Advisors LLC and 6 othersDirector, 10% OwnerPPurchase+1.41M$2.61+$3.67MNew position794.4K after9 lotsDuplicate filing

JANX Janux Therapeutics, Inc.

Director2 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Dec 30, 2021 (view filing)9:00 PM ETDec 291 dayOrbiMed Advisors LLC and 2 othersDirectorSSale−40.4K$20.30−$820.1K−14.9%231.1K after2 lotsDuplicate filing
Dec 23, 2021 (view filing)4:13 PM ETDec 212 daysOrbiMed Advisors LLC and 2 othersDirectorSSale−119.4K$19.00−$2.27M−33.7%234.8K after2 lotsDuplicate filing